Evidence map›Paper›PMID 32620082›Full record

ArticleBMC infectious diseases2020

Vascular function and cardiovascular risk in a HIV infected and HIV free cohort of African ancestry: baseline profile, rationale and methods of the longitudinal EndoAfrica-NWU study.

Carla M T Fourie, Shani Botha-Le Roux, Wayne Smith, Aletta E Schutte, Yolandi Breet, Carina M C Mels, Lebo F Gafane-Matemane, Leandi Lammertyn, Lisa Uys, Adele Burger and 4 more

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 4 countries.

Carla M T FourieHypertension in Africa Research Team (HART), North-West University, Private Bag X1290, Potchefstroom, South Africa. carla.fourie@nwu.ac.za.ORCID http://orcid.org/0000-0003-1950-1553
Shani Botha-Le RouxHypertension in Africa Research Team (HART), North-West University, Private Bag X1290, Potchefstroom, South Africa.
Wayne SmithHypertension in Africa Research Team (HART), North-West University, Private Bag X1290, Potchefstroom, South Africa.
Aletta E SchutteHypertension in Africa Research Team (HART), North-West University, Private Bag X1290, Potchefstroom, South Africa.
Yolandi BreetHypertension in Africa Research Team (HART), North-West University, Private Bag X1290, Potchefstroom, South Africa.
Carina M C MelsHypertension in Africa Research Team (HART), North-West University, Private Bag X1290, Potchefstroom, South Africa.
Lebo F Gafane-MatemaneHypertension in Africa Research Team (HART), North-West University, Private Bag X1290, Potchefstroom, South Africa.
Leandi LammertynHypertension in Africa Research Team (HART), North-West University, Private Bag X1290, Potchefstroom, South Africa.
Lisa UysHypertension in Africa Research Team (HART), North-West University, Private Bag X1290, Potchefstroom, South Africa.
Adele BurgerHypertension in Africa Research Team (HART), North-West University, Private Bag X1290, Potchefstroom, South Africa.
Jitcy S JosephToxicology and Biochemistry Department, National Institute for Occupational Health, Johannesburg, South Africa.
Nandu GoswamiGravitational Physiology and Medicine Research Unit, Division of Physiology, Medical University of Graz, Graz, Austria.
Patrick De BoeverHealth Unit, Flemish Institute for Technological Research (VITO), Mol, Belgium.
Hans StrijdomCentre for Cardiometabolic Research in Africa, Division of Medical Physiology, Faculty of Medicine and Health Sciences, Stellenbosch University, Stellenbosch, South Africa.
South African Medical Research Council · ZAMedical University of Graz · ATNational Institute for Occupational Health · ZAStellenbosch University · ZAUniversity of Antwerp · BE

Funding

Belgian Science Policy BL/67/eranet03Österreichische Agentur für Internationale Mobilität und Kooperation in Bildung, Wissenschaft und Forschung KEF-Projekt P202South African Department of Science and Technology DST/CON 0077/2014South African National Research Foundation SARChI GUN 86895
6 · The paper itself

Abstract

backgroundPeople living with the Human Immunodeficiency Virus (PLHIV) have an increased susceptibility to develop non-communicable diseases such as cardiovascular disease (CVD). Infection with HIV contributes to the development of CVD independent of traditional risk factors, with endothelial dysfunction being the central physiological mechanism. While HIV-related mortality is declining due to antiretroviral treatment (ART), the number of deaths due to CVD is rising in South Africa - the country with the highest number of PLHIV and the world's largest ART programme. The EndoAfrica study was developed to determine whether HIV infection and ART are associated with cardiovascular risk markers and changes in vascular structure and function over 18 months in adults from different provinces of South Africa. This paper describes the rationale, methodology and baseline cohort profile of the EndoAfrica study conducted in the North West Province, South Africa.

methodsIn this case-control study, conducted between August 2017 and June 2018, 382 volunteers of African descent (276 women; 106 men), comprising of 278 HIV infected and 104 HIV free individuals were included. We measured health behaviours, a detailed cardiovascular profile, and performed biomarker analyses. We compared baseline characteristics, blood pressure, vascular function and biochemical markers between those infected and HIV free.

resultsAt baseline, the HIV infected participants were older (43 vs 39 years), less were employed (21% vs 40%), less had a tertiary education (7% vs 16%) and their body mass index was lower (26 vs 29 kg/m

conclusionDespite PLHIV being older, preliminary cross-sectional analysis suggests that PLHIV being treated with ART do not have poorer endothelial or vascular function compared to the HIV free participants. More detailed analyses on the baseline and follow-up data will provide further clarity regarding the cardiovascular profile of South Africans living with HIV.

Indexed as

HIVAcquired Immunodeficiency SyndromeAdultAnti-Retroviral AgentsBiomarkersBlood PressureCardiovascular DiseasesCase-Control StudiesCholesterol, HDLCross-Sectional StudiesFemaleGlycated HemoglobinHumansLongitudinal StudiesMaleMiddle AgedAnti-Retroviral AgentsBiomarkersCholesterol, HDLGlycated Hemoglobinhemoglobin A1c protein, humanTriglyceridesAfrican ancestryAntiretroviral therapyCardiovascular risk markersEndothelial functionHIVSouth AfricaVascular function

Identifiers

PMID32620082
PMCPMC7333423
OpenAlexW3038961553

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.